A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
about
A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
description
clinical trial
@en
klinisch onderzoek
@nl
name
A 12-week Study Treating Parti ...... lvelestat (MPH966) or Placebo.
@en
type
label
A 12-week Study Treating Parti ...... lvelestat (MPH966) or Placebo.
@en
prefLabel
A 12-week Study Treating Parti ...... lvelestat (MPH966) or Placebo.
@en
P17
P6153
P1476
A Phase 2, Proof-of-concept, M ...... r Null) Antitrypsin Deficiency
@en
P1813
ASTRAEUS
@en
P3098
NCT03636347
P580
2018-10-31T00:00:00Z
P582
2019-09-02T00:00:00Z